Pregabalin
Important information for patients.
Pregabalin Reddy belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder in adults.
Neuropathic pain of peripheral and central origin: Pregabalin Reddy is used to treat long-lasting pain caused by nerve damage. Many different diseases, such as diabetes or shingles, can cause peripheral neuropathic pain. Painful sensations can be described as a feeling of heat, burning, pulsating, shooting, stabbing, sharp pain, cramps, aching, tingling, or numbness. Peripheral and central neuropathic pain can also be associated with mood changes, sleep disturbances, fatigue, which can affect the patient's physical and social functioning and overall quality of life.
Epilepsy: Pregabalin Reddy is used to treat certain types of epilepsy (partial seizures, which are or are not secondarily generalized) in adults. The doctor may prescribe Pregabalin Reddy if the current treatment does not fully control the course of the disease. Pregabalin Reddy should always be used as an add-on therapy to the currently used treatment. Pregabalin Reddy should not be used as monotherapy, but always in combination with other antiepileptic drugs.
Generalized anxiety disorder:Pregabalin Reddy is used to treat generalized anxiety disorder (GAD). GAD symptoms include prolonged, excessive anxiety and worry that are difficult to control. GAD can also cause restlessness, nervousness, or feeling on edge, easy fatigability, difficulty concentrating or feeling of "emptiness in the head", irritability, increased muscle tension, or sleep disturbances. Symptoms are different from the stresses and tensions of everyday life.
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Before starting to take Pregabalin Reddy, you should discuss it with your doctor or pharmacist.
Dependence
Some people may become dependent on Pregabalin Reddy (need to continue taking the medicine). After stopping Pregabalin Reddy, withdrawal symptoms may occur (see section 3 "How to take Pregabalin Reddy" and "Stopping Pregabalin Reddy"). If you are concerned that you may become dependent on Pregabalin Reddy, you should discuss this with your doctor.
If you experience any of the following symptoms while taking Pregabalin Reddy, it may indicate dependence:
The safety and efficacy of pregabalin in children and adolescents (under 18 years of age) have not been established, so pregabalin should not be used in this age group.
You should tell your doctor or pharmacist about all the medicines you are currently taking, or have recently taken, and about any medicines you plan to take.
Pregabalin Reddy and some medicines may interact with each other (interactions). When taken with other medicines with a sedating effect (e.g., opioids), Pregabalin Reddy may enhance these effects and cause respiratory failure, coma, and death. The degree of dizziness, drowsiness, and decreased concentration may increase if Pregabalin Reddy is taken with medicines containing:
Pregabalin Reddy can be taken with oral contraceptives.
Pregabalin Reddy capsules can be taken with or without food.
You should not drink alcohol while taking Pregabalin Reddy.
Pregabalin Reddy should not be taken during pregnancy or breastfeeding, unless your doctor decides otherwise. Taking pregabalin during the first 3 months of pregnancy may cause birth defects in the unborn child that require treatment. A Scandinavian study analyzing data from women who took pregabalin during the first 3 months of pregnancy showed birth defects in 6 out of every 100 born children, while in women who were not treated with pregabalin, birth defects occurred in 4 out of every 100 born children. The reported birth defects involved the face (cleft lip and palate), eyes, nervous system (including the brain), kidneys, and genital organs.
Women of childbearing age should use effective contraception. If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
Pregabalin Reddy may cause dizziness, drowsiness, and decreased concentration. You should not drive a car, operate complex machines, or perform potentially hazardous activities until you know how the medicine affects you.
If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per hard capsule, which means that the medicine is considered "sodium-free".
This medicine should always be taken exactly as prescribed by your doctor. If you are unsure, you should consult your doctor or pharmacist. Do not take more of the medicine than prescribed.
Your doctor will determine the dose of the medicine that is right for you.
Pregabalin Reddy is for oral use only.
If you feel that Pregabalin Reddy is too strong or too weak, you should tell your doctor or pharmacist.
Patients over 65 years of age should take Pregabalin Reddy according to the presented schedule, unless they have kidney problems.
In patients with impaired renal function, the doctor may decide on a different dosing schedule and/or change the dose of the medicine.
The capsule should be swallowed whole and washed down with water.
Pregabalin Reddy should be taken for as long as your doctor prescribes, and the treatment can only be stopped on the doctor's advice.
You should tell your doctor or go to the nearest hospital emergency department immediately. You should take the packaging or bottle of Pregabalin Reddy with you. After taking a higher dose of Pregabalin Reddy than prescribed, you may feel drowsy, confused, agitated, or restless. There have also been reports of seizures and loss of consciousness (coma).
It is important to take Pregabalin Reddy regularly at the same times every day. If you miss a dose, you should take it as soon as possible, unless it is almost time for the next dose. In this case, you should continue treatment according to the prescribed schedule. Do not take a double dose to make up for the missed dose.
You should not stop taking Pregabalin Reddy suddenly. If you want to stop taking Pregabalin Reddy, you should first talk to your doctor. Your doctor will tell you how to do it. If the treatment needs to be stopped, it should be done gradually over at least one week. You should be aware that after stopping short-term or long-term treatment with Pregabalin Reddy, certain side effects may occur, known as withdrawal symptoms. These symptoms include sleep disturbances, headache, nausea, anxiety, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, excessive sweating, and dizziness. These symptoms may be more frequent or severe if you have taken Pregabalin Reddy for a longer period. If you experience withdrawal symptoms, you should contact your doctor.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, Pregabalin Reddy can cause side effects, although not everybody gets them.
You should be aware that after stopping short-term or long-term treatment with Pregabalin Reddy, certain side effects may occur, known as withdrawal symptoms (see section "Stopping Pregabalin Reddy").
Some side effects, such as drowsiness, may occur more frequently because patients with spinal cord injury may be taking other medicines, such as painkillers or muscle relaxants, which have similar side effects to Pregabalin Reddy, and the severity of these effects may be greater when such medicines are taken at the same time.
After the medicine was placed on the market, the following side effects were also reported: breathing difficulties, shallow breathing.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49-21-301, fax: +48 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton or bottle after: EXP. The expiry date refers to the last day of the month stated.
There are no special precautions for storing the medicine.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Pregabalin Reddy, 25 mg, hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Reddy, 50 mg, hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Reddy, 75 mg, hard capsules
Each hard capsule contains 75 mg of pregabalin.
Pregabalin Reddy, 100 mg, hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Reddy, 150 mg, hard capsules
Each hard capsule contains 150 mg of pregabalin.
Pregabalin Reddy, 200 mg, hard capsules
Each hard capsule contains 200 mg of pregabalin.
Pregabalin Reddy, 225 mg, hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Reddy, 300 mg, hard capsules
Each hard capsule contains 300 mg of pregabalin.
Pregabalin Reddy, 25 mg, 50 mg, 150 mg, hard capsules
Capsule contents: lactose monohydrate, cornstarch, talc
Capsule shell: gelatin, titanium dioxide (E 171), sodium lauryl sulfate
Ink: shellac, iron oxide black (E 172), potassium hydroxide.
Pregabalin Reddy, 75 mg, 100 mg, 200 mg, 225 mg, 300 mg, hard capsules
Capsule contents: lactose monohydrate, cornstarch, talc
Capsule shell: gelatin, titanium dioxide (E 171), sodium lauryl sulfate, iron oxide red (E 172)
Ink: shellac, iron oxide black (E 172), potassium hydroxide.
Pregabalin Reddy, hard capsules, 25 mg:
PVC/PVDC/Aluminum blister pack containing 56 capsules in a carton.
Pregabalin Reddy, hard capsules, 50 mg:
PVC/PVDC/Aluminum blister pack containing 56 capsules in a carton.
Pregabalin Reddy, hard capsules, 75 mg:
PVC/PVDC/Aluminum blister pack containing 56 or 84 capsules in a carton.
Pregabalin Reddy, hard capsules, 100 mg:
PVC/PVDC/Aluminum blister pack containing 84 capsules in a carton.
Pregabalin Reddy, hard capsules, 150 mg:
PVC/PVDC/Aluminum blister pack containing 56 or 84 capsules in a carton.
What Pregabalin Reddy looks like and contents of the pack | |
25 mg capsules | Opaque capsules with a white cap and opaque white body with "RDY" printed on the cap and "291" on the body in black ink. Size 4 (14.3 ± 0.4 mm). |
50 mg capsules | Opaque capsules with a white cap and opaque white body with "RDY" printed on the cap and "292" on the body in black ink. The capsule body is marked with a black band. Size 3 (15.9 ± 0.4 mm). |
75 mg capsules | Opaque capsules with a red cap and opaque white body with "RDY" printed on the cap and "293" on the body in black ink. Size 4 (14.3 ± 0.4 mm). |
100 mg capsules | Opaque capsules with a red cap and opaque red body with "RDY" printed on the cap and "294" on the body in black ink. Size 3 (15.9 ± 0.4 mm). |
150 mg capsules | Opaque capsules with a white cap and opaque white body with "RDY" printed on the cap and "295" on the body in black ink. Size 2 (17.8 ± 0.4 mm). |
200 mg capsules | Opaque capsules with a light red cap and light red body with "RDY" printed on the cap and "296" on the body in black ink. Size 1 (19.2 ± 0.4 mm). |
225 mg capsules | Opaque capsules with a light red cap and white body with "RDY" printed on the cap and "297" on the body in black ink. Size 1 (19.2 ± 0.4 mm). |
300 mg capsules | Opaque capsules with a red cap and white body with "RDY" printed on the cap and "298" on the body in black ink. Size 0 (21.4 ± 0.4 mm). |
Pregabalin Reddy, hard capsules, 200 mg:
PVC/PVDC/Aluminum blister pack containing 84 capsules in a carton.
Pregabalin Reddy, hard capsules, 225 mg:
PVC/PVDC/Aluminum blister pack containing 56 capsules in a carton.
Pregabalin Reddy, hard capsules, 300 mg:
PVC/PVDC/Aluminum blister pack containing 56 capsules in a carton.
Not all pack sizes may be marketed.
Marketing authorization holder:
Reddy Holding GmbH
Kobelweg 95
86156 Augsburg
Germany
Tel.: +49 821 74881 0
Manufacturer/Importer:
Betapharm Arzneimittel GmbH
Kobelweg 95
86156 Augsburg
Germany
Germany
Pregabalin beta 25, 50, 75, 100, 150, 200, 225, 300 mg hard capsules
Austria
Pregabalin Reddy 25, 50, 75, 100, 150, 200, 225, 300 mg hard capsules
Czech Republic
Pregabalin Reddy
Netherlands
Pregabaline Reddy 25, 50, 75, 100, 150, 200, 225, 300 mg hard capsules
Poland
Pregabalin Reddy
Slovakia
Pregabalin Reddy 25, 50, 75, 100, 150, 200, 225, 300 mg hard capsules
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.